Navasota Resources Inc.
NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solut… Read more
Navasota Resources Inc. (NAV) - Net Assets
Latest net assets as of : CA$- CAD
Based on the latest financial reports, Navasota Resources Inc. (NAV) has net assets worth CA$- CAD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$-) and total liabilities (CA$-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$- |
| % of Total Assets | 0% |
| Annual Growth Rate | -96.43% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Navasota Resources Inc. - Net Assets Trend (2021–2022)
This chart illustrates how Navasota Resources Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Navasota Resources Inc. (2021–2022)
The table below shows the annual net assets of Navasota Resources Inc. from 2021 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-09-30 | CA$3.47K | -96.43% |
| 2021-09-30 | CA$97.15K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Navasota Resources Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9368000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2022)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$405.57K | 11681.28% |
| Total Equity | CA$3.47K | 100.00% |
Navasota Resources Inc. Competitors by Market Cap
The table below lists competitors of Navasota Resources Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BTS GROUP -B-
BE:BX1B
|
$132.93K |
|
Putprop Ltd
JSE:PPR
|
$132.96K |
|
Mennica Skarbowa SA
WAR:MNS
|
$133.08K |
|
Etex SA
BR:BE0941244536
|
$133.16K |
|
HEALTH AND PL.PROT.GROUP
F:0EG0
|
$132.88K |
|
EMBR3F
SA:EMBR3F
|
$132.83K |
|
CI U.S. Monthly Income Private Pool
TO:CUIG
|
$132.76K |
|
All Things Mobile Analytic Inc
PINK:ATMH
|
$132.73K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Navasota Resources Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 97,152 to 3,472, a change of -93,680 (-96.4%).
- Net loss of 93,680 reduced equity.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-93.68K | -2698.16% |
| Total Change | CA$- | -96.43% |
Book Value vs Market Value Analysis
This analysis compares Navasota Resources Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.62x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.24x to 6.62x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-09-30 | CA$0.02 | CA$0.01 | x |
| 2022-09-30 | CA$0.00 | CA$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Navasota Resources Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2698.16%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 32.31x
- Recent ROE (-2698.16%) is below the historical average (-1387.21%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -76.25% | 0.00% | 0.00x | 1.19x | CA$-83.80K |
| 2022 | -2698.16% | 0.00% | 0.00x | 32.31x | CA$-94.03K |
Industry Comparison
This section compares Navasota Resources Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $157,095,088
- Average return on equity (ROE) among peers: -37.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Navasota Resources Inc. (NAV) | CA$- | -76.25% | N/A | $132.92K |
| Amotiv Limited (AOV) | $1.03 Billion | 2.34% | 0.02x | $227.52 Million |
| Cannabist Company Holdings Inc (CBST) | $-986.97K | 0.00% | 0.00x | $11.81 Million |
| DRI Healthcare Trust (DHT-U) | $372.34 Million | 3.11% | 0.70x | $450.44 Million |
| GenixPharmaceucticals Corporation (GENX) | $4.01 Million | -41.17% | 0.19x | $451.93K |
| Simply Solventless Concentrates Ltd. (HASH) | $1.78 Million | -130.46% | 0.98x | $2.81 Million |
| The Hempshire Group Corp. (HMPG) | $-835.46K | 0.00% | 0.00x | $515.15K |
| LSL Pharma Group Inc. (LSL) | $7.48 Million | 1.18% | 2.18x | $24.09 Million |
| Good Shroom Co Inc (MUSH) | $242.01K | -170.37% | 3.22x | $2.78 Million |
| Verano Holdings Corp Ordinary Shares - Class A (Sub Voting) (VRNO) | $-216.50K | 0.00% | 0.00x | $303.72 Million |